A collation of 19 distinct data sets were used to measure trends in copy number aberrations between cancer types
| Site/diagnosis | Sample type | n | Source | Probe type | No. probes |
|---|---|---|---|---|---|
| Breast | Tumors | 47 | Penn database | BAC | 4,135 |
| Tumors | 43 | Pollack et al. ( 36) | cDNA | 5,686 | |
| Cell lines | 22 | Penn database | BAC | 4,135 | |
| Ovary | Tumors | 76 | Penn database | BAC | 4,135 |
| Cell lines | 27 | Penn database | BAC | 4,135 | |
| Sarcoma | Tumors | 63 | Penn database | BAC | 4,135 |
| Cell lines | 18 | Penn database | BAC | 4,135 | |
| Melanoma | Tumors | 20 | Penn database | BAC | 4,135 |
| Tumors | 126 | Curtin et al. ( 28) | BAC | 2,463 | |
| Cell lines | 42 | Penn database | BAC | 4,135 | |
| Colon | Tumors | 125 | Nakao et al. ( 26) | BAC | 2,463 |
| Tumors | 37 | Douglas et al. ( 25) | BAC | 3,500 | |
| Tumors | 50 | Mehta et al. (46) | BAC | 3,500 | |
| Cell lines | 48 | Douglas et al. ( 25) | BAC | 3,500 | |
| Pancreas | Tumors | 13 | Aguirre et al. ( 12) | cDNA | 14,120 |
| Cell lines | 24 | Aguirre et al. ( 12) | cDNA | 14,120 | |
| Lung | Tumors | 51 | Zhao et al. ( 21) | SNP | 115,593 |
| Cell lines | 20 | Zhao et al. ( 21) | SNP | 115,593 | |
| Cell lines | 20 | Garnis et al. ( 20) | BAC | 32,000 | |
| Tumor totals | 651 | ||||
| Cell line totals | 221 | ||||
| Grand totals | 872 | ||||